Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone

The Prostate ◽  
2014 ◽  
Vol 74 (14) ◽  
pp. 1462-1464 ◽  
Author(s):  
Raya Leibowitz-Amit ◽  
Nimira Alimohamed ◽  
Francisco E. Vera-Badillo ◽  
Jo-An Seah ◽  
Arnoud J. Templeton ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Castrate Resistant Prostate Cancer ◽  
Castrate Resistant

scholarly journals 225Actinium-labeled prostate-specific membrane antigen targeting peptide induces complete response in a metastatic prostate cancer patient

2021 ◽  
Vol 10 (5) ◽  
pp. 205846012110225
Author(s):  
Omer Aras ◽  
Stefan Harmsen ◽  
Richard Ting ◽  
Haluk B Sayman
Keyword(s):  
Prostate Cancer ◽  
Standard Of Care ◽  
Complete Response ◽  
Prostate Specific Membrane Antigen ◽  
Limited Data ◽  
Castrate Resistant Prostate Cancer ◽  
Targeting Peptide ◽  
Castrate Resistant ◽  
Specific Membrane

Targeted radionuclide therapy has emerged as a promising and potentially curative strategy for high-grade prostate cancer. However, limited data are available on efficacy, quality of life, and pretherapeutic biomarkers. Here, we highlight the case of a patient with prostate-specific membrane antigen (PSMA)-positive metastatic castrate-resistant prostate cancer who displayed complete response to 225Ac-PSMA-617 after having been resistant to standard-of-care therapy, then initially partially responsive but later resistant to subsequent immunotherapy, and resistant to successive 177Lu-PSMA-617. In addition, the patient’s baseline germline mutation likely predisposed him to more aggressive disease.

A phase II trial of weekly i.v. KW-2170 in advanced castrate-resistant prostate cancer

2010 ◽  
Vol 6 (4) ◽  
pp. 292-297 ◽  
Author(s):  
Paul L DE SOUZA ◽  
Scott NORTH ◽  
Graeme B BOLGER ◽  
Harris SPIRIDONIDIS ◽  
Robert LIM ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Castrate Resistant Prostate Cancer ◽  
Castrate Resistant

2567 Efficacy and tolerability of Docetaxel in patients with metastatic castrate-resistant prostate cancer older than 70 years compared with younger patients

2015 ◽  
Vol 51 ◽  
pp. S500
Author(s):  
M.C. Dias Ferreira Maia ◽  
N. Moreno Perez Fraile ◽  
L. Valente Lage ◽  
R. Barosso Souza ◽  
C. Dzik ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Younger Patients ◽  
Castrate Resistant Prostate Cancer ◽  
Castrate Resistant
Sign in / Sign up

Export Citation Format

Share Document